Drug Profile
Research programme: cannabinoid-based cancer therapeutics - Cannabis Science/Dana Farber/Harvard Cancer Center
Alternative Names: Cannabinoid cancer compounds - Cannabis Science/Dana Farber/Harvard Cancer CenterLatest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Cannabis Science; Dana-Farber/Harvard Cancer Center
- Class Antineoplastics; Cannabinoids
- Mechanism of Action Cannabinoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer